Difference between revisions of "2016-01-13 PLA WGM Agenda"

From HL7 TSC
Jump to navigation Jump to search
 
(One intermediate revision by the same user not shown)
Line 42: Line 42:
 
| || Woody Beeler  
 
| || Woody Beeler  
 
|-
 
|-
| ||Lorraine Constable
+
|x ||Lorraine Constable
 
|-
 
|-
 
| ||Bo Dagnall
 
| ||Bo Dagnall
Line 58: Line 58:
 
| || Lynn Laakso
 
| || Lynn Laakso
 
|-
 
|-
| || Mary Kay McDaniel
+
| x|| Mary Kay McDaniel
 
|-
 
|-
 
| || Brian Pech
 
| || Brian Pech
Line 86: Line 86:
 
*Agenda review
 
*Agenda review
 
*Discussion Topics:
 
*Discussion Topics:
 +
**V2 status
 +
**Discuss V2 methodology – InM coordinating with CGIT
  
 
*notional division of products into product families and lines, to provide examples for peer review.
 
*notional division of products into product families and lines, to provide examples for peer review.
Line 96: Line 98:
  
 
===Minutes===
 
===Minutes===
 +
*V2 publishing
 +
**Reach out to publishing for update to M&C
 +
*Discuss V2 methodology – InM coordinating with CGIT and Vocabulary
 +
**Reach out to InM – invite all co-chairs to call to discuss next steps for integration.
 +
**SGB will take over governance for 2.x
 +
**Does V2 publishing group stop reporting to SD and report directly to SGB? Can publishing move in pieces?
  
 +
*ACTIONS:
 +
**1) outreach to InM; formal request/notification to SGB to tell them that they’re providing governance to 2.x (Mary Kay will send email to chairs)
 +
**2) Clarify who approves standing up a product family management group and methodology group  – looks as though it would be approved by SGB and then by TSC (Check with Tony)
 +
**3) Obtain an inventory of the product
 +
**4) Craft  form for product family creation
 
===Meeting Outcomes===
 
===Meeting Outcomes===
 
{|border="1" cellpadding="2" cellspacing="0"  
 
{|border="1" cellpadding="2" cellspacing="0"  

Latest revision as of 18:41, 24 February 2016

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes

Location: Plaza International Ballroom I

Date: 2016-01-13
Time: 3:30 PM Eastern
Facilitator Mary Kay/ Austin Note taker(s) Anne
Attendee Name


Calvin Beebe
Woody Beeler
x Lorraine Constable
Bo Dagnall
Jean Duteau,
Rick Haddorff
Tony Julian
Paul Knapp
x Austin Kreisler,
Lynn Laakso
x Mary Kay McDaniel
Brian Pech
John Quinn
John Roberts
Andy Stechishin
no quorum definition

Agenda

  • Agenda review
  • Discussion Topics:
    • V2 status
    • Discuss V2 methodology – InM coordinating with CGIT
  • notional division of products into product families and lines, to provide examples for peer review.
    • Level of granularity
    • Identify which pieces are orphaned, and the political elements to be surfaced.
    • Positioning cross-product family artifacts (standards naming)
  • BAM-lite feedback and review
    • Governance on V2.x (v2.9 substantive changes)
    • develop form to request establishing a Product Family

Minutes

  • V2 publishing
    • Reach out to publishing for update to M&C
  • Discuss V2 methodology – InM coordinating with CGIT and Vocabulary
    • Reach out to InM – invite all co-chairs to call to discuss next steps for integration.
    • SGB will take over governance for 2.x
    • Does V2 publishing group stop reporting to SD and report directly to SGB? Can publishing move in pieces?
  • ACTIONS:
    • 1) outreach to InM; formal request/notification to SGB to tell them that they’re providing governance to 2.x (Mary Kay will send email to chairs)
    • 2) Clarify who approves standing up a product family management group and methodology group – looks as though it would be approved by SGB and then by TSC (Check with Tony)
    • 3) Obtain an inventory of the product
    • 4) Craft form for product family creation

Meeting Outcomes

Actions

© 2016 Health Level Seven® International. All rights reserved